Copperwynd Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63M Buy
4,031
+601
+18% +$244K 0.41% 44
2025
Q1
$1.71M Buy
3,430
+1,020
+42% +$508K 0.47% 39
2024
Q4
$1.25M Sell
2,410
-737
-23% -$383K 0.35% 51
2024
Q3
$1.95M Buy
3,147
+187
+6% +$116K 0.59% 31
2024
Q2
$1.82M Buy
2,960
+356
+14% +$218K 0.59% 30
2024
Q1
$1.51M Buy
2,604
+191
+8% +$111K 0.54% 34
2023
Q4
$1.28M Buy
2,413
+135
+6% +$71.7K 0.51% 36
2023
Q3
$1.15M Buy
2,278
+29
+1% +$14.7K 0.54% 32
2023
Q2
$1.17M Buy
2,249
+49
+2% +$25.6K 0.55% 40
2023
Q1
$1.27M Buy
2,200
+787
+56% +$454K 0.65% 37
2022
Q4
$778K Sell
1,413
-48
-3% -$26.4K 0.44% 52
2022
Q3
$741K Sell
1,461
-90
-6% -$45.6K 0.43% 46
2022
Q2
$842K Sell
1,551
-31
-2% -$16.8K 0.5% 43
2022
Q1
$934K Buy
1,582
+39
+3% +$23K 0.39% 42
2021
Q4
$1.03M Sell
1,543
-34
-2% -$22.7K 0.39% 36
2021
Q3
$901K Sell
1,577
-17
-1% -$9.71K 0.37% 43
2021
Q2
$804K Buy
1,594
+31
+2% +$15.6K 0.34% 43
2021
Q1
$713K Sell
1,563
-118
-7% -$53.8K 0.32% 40
2020
Q4
$783K Sell
1,681
-98
-6% -$45.6K 0.38% 40
2020
Q3
$785K Sell
1,779
-77
-4% -$34K 0.42% 35
2020
Q2
$672K Sell
1,856
-194
-9% -$70.2K 0.38% 34
2020
Q1
$581K Sell
2,050
-245
-11% -$69.4K 0.28% 22
2019
Q4
$745K Buy
2,295
+36
+2% +$11.7K 0.39% 41
2019
Q3
$663K Buy
2,259
+122
+6% +$35.8K 0.38% 40
2019
Q2
$627K Sell
2,137
-27
-1% -$7.92K 0.36% 37
2019
Q1
$592K Buy
2,164
+14
+0.7% +$3.83K 0.35% 40
2018
Q4
$481K Sell
2,150
-89
-4% -$19.9K 0.3% 33
2018
Q3
$546K Buy
2,239
+33
+1% +$8.05K 0.33% 45
2018
Q2
$457K Buy
2,206
+13
+0.6% +$2.69K 0.32% 42
2018
Q1
$453K Buy
2,193
+137
+7% +$28.3K 0.31% 44
2017
Q4
$390K Buy
+2,056
New +$390K 0.28% 57